Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1092056.RAcGpMChHVNO4hcXDWfQXUbMvfBoeEXNZea8CIESlrUfo130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1092056.RAcGpMChHVNO4hcXDWfQXUbMvfBoeEXNZea8CIESlrUfo130_assertion type Assertion NP1092056.RAcGpMChHVNO4hcXDWfQXUbMvfBoeEXNZea8CIESlrUfo130_head.
- NP1092056.RAcGpMChHVNO4hcXDWfQXUbMvfBoeEXNZea8CIESlrUfo130_assertion description "[The objectives of the study were: 1) to determine the prevalence of TERT promoter mutations C228T and C250T in different thyroid cancer histological types and cell lines; and 2) to establish the possible association of TERT mutations with mutations of BRAF, RAS, or RET/PTC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1092056.RAcGpMChHVNO4hcXDWfQXUbMvfBoeEXNZea8CIESlrUfo130_provenance.
- NP1092056.RAcGpMChHVNO4hcXDWfQXUbMvfBoeEXNZea8CIESlrUfo130_assertion evidence source_evidence_literature NP1092056.RAcGpMChHVNO4hcXDWfQXUbMvfBoeEXNZea8CIESlrUfo130_provenance.
- NP1092056.RAcGpMChHVNO4hcXDWfQXUbMvfBoeEXNZea8CIESlrUfo130_assertion SIO_000772 23833040 NP1092056.RAcGpMChHVNO4hcXDWfQXUbMvfBoeEXNZea8CIESlrUfo130_provenance.
- NP1092056.RAcGpMChHVNO4hcXDWfQXUbMvfBoeEXNZea8CIESlrUfo130_assertion wasDerivedFrom befree-2016 NP1092056.RAcGpMChHVNO4hcXDWfQXUbMvfBoeEXNZea8CIESlrUfo130_provenance.
- NP1092056.RAcGpMChHVNO4hcXDWfQXUbMvfBoeEXNZea8CIESlrUfo130_assertion wasGeneratedBy ECO_0000203 NP1092056.RAcGpMChHVNO4hcXDWfQXUbMvfBoeEXNZea8CIESlrUfo130_provenance.